Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2036.2002.01169.xPMID 11860399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Helicobacter pylori - Wann und wie behandeln sich Gastroenterologen selbst? - Eine Umfrage in Klinik und Praxis

  2008cited by this paper
• [MALT lymphoma of the stomach: current state and perspectives].

  2008cited by this paper
• Long-term prospective study ofHelicobacter pylori in nonulcer dyspepsia

  2005cited by this paper
• Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies.

  2003cited by this paper
• One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease

  2001cited by this paper
• Blood, urine, stool, breath, money, andHelicobacter pylori

  2001cited by this paper
• Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pyloritreatment

  2001cited by this paper
• High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children

  2001cited by this paper
• Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

  2001cited by this paper
• When heredity is infectious.

  2000cited by this paper
• Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study

  2000cited by this paper
• Omeprazole and accelerated onset of atrophic gastritis.

  2000cited by this paper
• Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial.

  2000cited by this paper
• Helicobacter pylori infection in children: to test or not to test...what is the evidence?

  2000cited by this paper
• Omeprazole and accelerated onset of atrophic gastritis.

  2000cited by this paper
• How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs?

  2000cited by this paper
• An evaluation of whole blood testing for Helicobacter pylori infection in the Chinese population

  2000cited by this paper
• Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.

  2000cited by this paper
• Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

  2000cited by this paper
• How to treat Helicobacter pylori. First-line, second-line, and future therapies.

  2000cited by this paper
• Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia

  2000cited by this paper
• Management of Peptic Ulcers: Emerging Issues

  2000cited by this paper
• Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer in Japan.

  2000cited by this paper
• Helicobacter pylori infection in children: To test or not test...what is the eviedence?

  2000cited by this paper
• Latin-American Consensus Conference on Helicobacter pylori infection

  2000cited by this paper
• Helicobacter pylori and gastric cancer: the risk is real

  2000cited by this paper
• Helicobacter pylori infection among offspring of patients with stomach cancer.

  2000cited by this paper
• Comparison of tests for assessment of Helicobacter pylori eradication: results of a multi‐centre study using centralized facility testing

  2000cited by this paper
• Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

  2000cited by this paper
• Latin-American Consensus Conference on Helicobacter pylori infection 1 1 A list of delegates to the

  2000cited by this paper
• Role of Helicobacter pylori infection in NSAID-associated gastropathy

  2000cited by this paper
• Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori

  2000cited by this paper
• Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori.

  2000cited by this paper
• Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection.

  2000cited by this paper
• Helicobacter pylori Infection in Children: A Consensus Statement

  2000cited by this paper
• Primary prophylaxis of NSAID-induced gastroduodenal ulcers and dyspepsia in H. pylori (HP)-positive patients: Randomized, double-blind, placebo-controlled treatment of HP infection VS. omeprazole

  2000cited by this paper
• Elan study proves symptomatic benefit of Helicobacter pylori eradication in functional dyspepsia(FD)

  2000cited by this paper
• Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?

  2000cited by this paper
• Interleukin-1 polymorphisms associated with increased risk of gastric cancer

  2000cited by this paper
• Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group.

  2000cited by this paper
• HOW TO TREAT HELICOBACTER PYLORI

  2000cited by this paper
• Treatment of Helicobacter pylori infection in elderly subjects.

  2000cited by this paper
• Early negative results not the last word on secretin/autism story.

  2000cited by this paper
• Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care.

  2000cited by this paper
• High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis

  2000cited by this paper
• Treatment of Helicobacter pylori infection in elderly subjects.

  2000cited by this paper
• Short course acid suppressive treatment for patients with functional dyspepsia: results depend onHelicobacter pyloristatus

  2000cited by this paper
• Lack of effect of acid suppression therapy on gastric atrophy.

  2000cited by this paper
• Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.

  2000cited by this paper
• Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori.

  2000cited by this paper
• A TRIAL OF A TEST‐AND‐TREAT STRATEGY FOR HELICOBACTER PYLORI POSITIVE DYSPEPTIC PATIENTS IN GENERAL PRACTICE

  1999cited by this paper
• Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting

  1999cited by this paper
• Corpus gastritis is protective against reflux oesophagitis

  1999cited by this paper
• Non-gastrointestinal tract associations of Helicobacter pylori infection.

  1999cited by this paper
• Testing for Helicobacter pylori infection: validation and diagnostic yield of a near patient test in primary care

  1999cited by this paper
• Two‐ to four‐year histological follow‐up of gastric mucosa after Helicobacter pylori eradication

  1999cited by this paper
• A prospective randomised trial of a “test and treat” policy versus endoscopy based management in youngHelicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic

  1999cited by this paper
• Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study

  1999cited by this paper
• Helicobacter pylori and gastric cancer: time for mega-trials?

  1999cited by this paper
• The effect of Helicobacter pylori eradication on gastro‐oesophageal reflux

  1999cited by this paper
• Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group.

  1999cited by this paper
• Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group.

  1999cited by this paper
• Reversal of Iron Deficiency Anemia after Helicobacter pylori Eradication in Patients with Asymptomatic Gastritis

  1999cited by this paper
• Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia.

  1999cited by this paper
• Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis

  1999cited by this paper
• Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System.

  1999cited by this paper
• Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents.

  1999cited by this paper
• The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

  1999cited by this paper
• Risk indicators of organic diseases in uninvestigated dyspepsia: a one-week survey in 246 Italian endoscopy units.

  1999cited by this paper
• Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

  1999cited by this paper
• Estimates of the worldwide incidence of 25 major cancers in 1990

  1999cited by this paper
• The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

  1999cited by this paper
• Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.

  1999cited by this paper
• Review article: Helicobacter pylori and gastro‐oesophageal reflux disease—clinical implications and management

  1999cited by this paper
• Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.

  1999cited by this paper
• Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group.

  1999cited by this paper
• Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up

  1999cited by this paper
• Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

  1998cited by this paper
• Does cure of Helicobacter pylori infection induce heartburn

  1998cited by this paper
• One‐week clarithromycin triple therapy regimens for eradication of Helicobacter pylori

  1998cited by this paper
• Does Helicobacter pylori infection eradication modify peptic ulcer prevalence

  1998cited by this paper
• How Do Practicing Clinicians Manage Helicobacter pylori‐Related Gastrointestinal Diseases in Germany? A Survey of Gastroenterologists and Family Practitioners

  1998cited by this paper
• Guidelines for the management of Helicobacter pylori infection

  1998cited by this paper
• Antibiotic resistance in Helicobacter pylori : Implications for therapy

  1998cited by this paper
• Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

  1998cited by this paper
• New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.

  1998cited by this paper
• Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro‐oesophageal reflux disease

  1998cited by this paper
• Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

  1998cited by this paper
• Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies)

  1998cited by this paper
• A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia

  1998cited by this paper
• Omeprazole and sucralfate in the treatment of NSAID‐induced gastric and duodenal ulcer

  1998cited by this paper
• Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori.

  1998cited by this paper
• Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

  1998cited by this paper
• Antibiotic resistance in Helicobacter pylori: implications for therapy.

  1998cited by this paper
• Lack of Effect of TreatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia

  1998cited by this paper
• The relation of CAGA and the long term sequelae of gastritis after successful cure of H. pylori infection: a long term follow up study

  1998cited by this paper
• Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori.

  1998cited by this paper
• Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.

  1998cited by this paper
• How Do Clinicians Practicing in the U.S. Manage Helicobacter pylori-Related Gastrointestinal Diseases? A Comparison of Primary Care and Specialist Physicians

  1998cited by this paper
• Lessons from Ongoing Intervention Studies

  1998cited by this paper

• Probiotics in the treatment of helicobacter pylori infection: A bibliometric analysis from 2001 to 2025.

  2026cites this paper
• Bibliometric and visualisation analyses of gastric ulcer knowledge areas and emerging trends, 2004–2024

  2025cites this paper
• Fever phobias, perception among caregivers across Nigerian states: A systematic review and meta-analysis

  2025cites this paper
• Novel research in the field of non-invasive diagnostics of Helicobacter pylori utilizing a library of chemical piezoelectric sensors and portable devices

  2025cites this paper
• Should Metronidazole Be Included in Second‐Line Treatment After Standard Triple Therapy for Helicobacter pylori ?: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

  2025cites this paper
• Unveiling the potential of Lactobacillus johnsonii in digestive diseases: a comprehensive review

  2025cites this paper
• Diagnosis and treatment of Helicobacter pylori infection: past, present, and future.

  2025cites this paper
• SPR and Double Resonance LPG Biosensors for Helicobacter pylori BabA Antigen Detection

  2024cites this paper
• Weizmannia coagulans BC99 affects valeric acid production via regulating gut microbiota to ameliorate inflammation and oxidative stress responses in Helicobacter pylori mice.

  2024cites this paper
• Helicobacter pylori Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management

  2024cites this paper
• Adjuvant administration of probiotic effects on sexual function in depressant women undergoing SSRIs treatment: a double-blinded randomized controlled trial

  2024cites this paper
• The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh

  2024cites this paper
• A Comparative Study of Immunohistochemical, Hematoxylin and Eosin, and Giemsa Stains for Demonstration of Helicobacter pylori in Cases of Chronic Antral Gastritis

  2024cites this paper
• Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update

  2024cites this paper
• Initial assessment of "Gissell's stain": A novel histopathological method for the identification of Helicobacter pylori.

  2023cites this paper
• Antibiotic Resistance of Helicobacter pylori in Turkey: A Systematic Review and Meta-Analysis

  2023cites this paper
• 1983–2023 – Vierzig Jahre Helicobacter pylori – und nun?

  2023cites this paper
• Histopathologic Study of Gastritis and Helicobacter Pylori Infection at a Tertiary Centre in Kathmandu

  2023cites this paper
• Composition and Anti-Helicobacter pylori Properties of Essential Oils Obtained from Selected Mentha Cultivars

  2023cites this paper
• States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis

  2023cites this paper
• Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in Helicobacter pylori from Gastric Biopsies in Southern Croatia

  2023cites this paper
• Global research trends and hotspots of Helicobacter pylori eradication based on clinical trial registration platforms: a cross-sectional analysis.

  2023cites this paper
• Potential Biotherapeutic Effect of Lactobacillus reuteri NA1 on The Treatment of Induced Peptic Ulcer in Rats: Histopathological Study

  2022cites this paper
• The relationship between helicobacter pylori infection and nodular antral gastritis in pediatric patients.

  2022cites this paper
• Evaluation of the diagnostic performance and the utility of Helicobacter pylori stool antigen lateral immunochromatography assay

  2022cites this paper
• Bacterial metalo-aminopeptidases as targets in human infectious diseases.

  2022cites this paper
• Rapid Detection of Quinolone Resistance Mutations in gyrA of Helicobacter pylori by Real-Time PCR

  2022cites this paper
• The Role Of Probiotics In The Treatment Of Helicobacter Pylori-Caused Gastritis

  2022cites this paper
• The Effect of Quadruple Therapy with Polaprezinc or Bismuth on Gut Microbiota after Helicobacter pylori Eradication: A Randomized Controlled Trial

  2022cites this paper
• Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?

  2022cites this paper
• A Review on Helicobacter pylori Infection

  2022cites this paper
• Effect of metformin on the eradication of H.Pylori infection in 25 -75 years old patients referring Loghman Hakim Hospital

  2022cites this paper
• Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance rates

  2022cites this paper
• Evaluation of the Diagnostic Values and Utility of Helicobacter Pylori Stool Antigen Lateral Immunochromatography Assay

  2021cites this paper
• V Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2021cites this paper
• Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV‐positive than HIV‐negative individuals: A descriptive observational study

  2021cites this paper
• 40 Years of Helicobacter pylori: A Revolution in Biomedical Thought

  2021cites this paper
• Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial.

  2021cites this paper
• In vitro antimicrobial activity of douro wines against clinical Helicobacter Pylori Strains

  2021cites this paper
• Эпидемиологические аспекты инфицирования Нelicobacter pylori у детей

  2021cites this paper
• In Vitro Screening Potential Antibacterial Properties of the Greek Oregano Honey against Clinical Isolates of Helicobacter pylori

  2021cites this paper
• Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020

  2021cites this paper
• V Spanish Consensus Conference on Helicobacter pylori infection treatment.

  2021cites this paper
• Helicobacter Pylori Eradication Therapy: Still a Challenge

  2021cites this paper
• Lactobacillus plantarum ZJ316 Attenuates Helicobacter pylori-Induced Gastritis in C57BL/6 Mice.

  2021cites this paper
• Worldwide and Regional Efficacy Estimates of First-line Helicobacter pylori Treatments

  2021cites this paper
• Improving the ability of antimicrobial susceptibility tests to predict clinical outcome accurately: adding metabolic evasion to the equation.

  2021cites this paper
• Response of Helicobacter Pylori Eradication Treatment in Patients With Normal and Below-Normal Serum Vitamin D Levels

  2021cites this paper
• Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections

  2021cites this paper
• Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial.

  2021cites this paper
• Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive Review

  2021cites this paper
• Endoscopic Evaluation of Dyspeptic Patients

  2021cites this paper
• Dyspepsia Challenge in Primary Care Gastroenterology

  2021cites this paper
• GIST of the stomach masquerading as recurrent falls in an older adult: a case report and review

  2021cites this paper
• The Effect of Helicobacter pylori Eradication on Gastric Wall Thickness in Patients Undergoing Laparoscopic Sleeve Gastrectomy

  2021cites this paper
• Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (FTIR) and Artificial Neural Networks Applied to Investigate Quantitative Changes of Selected Soluble Biomarkers, Correlated with H. pylori Infection in Children and Presumable Consequent Delayed Growth

  2020cites this paper
• Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches

  2020cites this paper
• Evolution of Susceptibilities of Helicobacter pylori Strains Circulating in Cameroon to Usual Antibiotics: A Three-year Study

  2020cites this paper
• Prevalancy of cagA and babA of Helicobacter pylori isolated from gastric atrophic patients

  2020cites this paper
• ASSOCIATION OF GENDER AND AGE WITH COMPLIANCE OF H PYLORI ERADICATION THERAPY

  2020cites this paper
• Serious medical and ethical issues associated to the breath test and stool antigen test

  2020cites this paper
• Investigating the Efficacy of Triple Drug Therapy and Sequential Drug Therapy in the Eradication of Helicobacter Pylori with Respect to Antigen Stool test: A Pilot Study.

  2020cites this paper
• Association of tobacco smoke–infused water (tuibur) use by Mizo people and risk of Helicobacter pylori infection

  2020cites this paper
• Case Histories of Significant Medical Advances: Eradicating Helicobacter Pylori Infections to Treat Ulcers

  2020cites this paper
• The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis

  2020cites this paper
• Seroepidemiological Investigation of Antigen and Antibody for the Detection of Helicobacter Pylori Infection in a Rural Area of Nepal

  2020cites this paper
• Pharmacological Evaluation of Lavandula stoechas L. for Ethanol-induced Gastric Mucosal Ulcer

  2020cites this paper
• European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

  2020cites this paper
• How Should Helicobacter Pylori Eradication Be Performed in Cases of Extensive Allergies to Proton Pump Inhibitors?

  2020cites this paper
• Development of a Method for Assessing Helicobacter pylori Activity Based on Exhaled Air Composition with the Use of an Array of Piezoelectric Chemical Sensors

  2020cites this paper
• Formulation and evaluation of lansoprazole sublingual tablet

  2020cites this paper
• Helicobacter Pylori Eradication - A New Look at Old Problems

  2019cites this paper
• Role of Camphlobacter pylori and non steroidal anti-inflammatory drugs in the pathogenesis of peptic ulcer and pharmacological approaches for the treatment of peptic ulcer disease

  2019cites this paper
• Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial

  2019cites this paper
• Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study

  2019cites this paper
• Probiotic L. gasseri strain (LG21) for the upper gastrointestinal tract acting through improvement of indigenous microbiota

  2019cites this paper
• The effect of warming specimens of rapid urease test on its diagnostic accuracy

  2019cites this paper
• Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)

  2019cites this paper
• Influence of serum vitamin D level on Helicobacter pylori eradication: A multi‐center, observational, prospective and cohort study

  2019cites this paper
• Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial

  2019cites this paper
• Efficacy of Esomeprazole in NSAIDs Induced Gastric Ulcer: A Meta-Analysis

  2019cites this paper
• Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.

  2019cites this paper
• Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori

  2019cites this paper
• Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?

  2019cites this paper
• Herbal medicine as an auspicious therapeutic approach for the eradication of Helicobacter pylori infection: A concise review

  2019influential citation
• Erosive And Non-Erosive Forms Of Gastroesophageal Reflux Disease

  2019cites this paper
• Diagnostic approach & pharmacological treatment regimen of Peptic Ulcer Disease

  2019cites this paper
• 1 Helicobacter pylori Infection and Undiagnosed Dyspepsia in Dyspeptic Populations Under 45 of Age Tested by ELISA , Urease Breath Test and Helicotest Ma ł gorzata

  2019cites this paper
• Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study.

  2019cites this paper
• Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions

  2019cites this paper
• Role of Probiotics in Prophylaxis of Helicobacter pylori Infection.

  2019cites this paper
• Real‐time PCR for Helicobacter pylori diagnosis. The best tools available

  2018cites this paper
• Improvement of the Quality of Life Following the Eradication of Helicobacter Pylori Infection in Patients with Chronic Idiopathic Urticaria

  2018cites this paper
• When human cells meet bacteria: precision medicine for cancers using the microbiota.

  2018cites this paper
• Prevalence of Helicobacter pylori in Southern Part of Iran

  2018cites this paper
• Introduction

  2018cites this paper
• Gastric Microenvironment Enables Persistence of Helicobacter pylori: a Physician's Combat Towards Eradication and Directions for the Future

  2018cites this paper
• Treatment of Helicobacter pylori infection: A clinical practice update

  2018cites this paper
• A Two-Week Nitazoxanide-Based Quadruple Treatment as a Rescue Therapy for Helicobacter Pylori Eradication

  2018cites this paper
• Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection.

  2018cites this paper